NSAID hepatotoxicity

Contemporary Ob-Gyn

Volumn 41, Issue 11, 1996, Pages 81-101

  Lewis, James H ^a   Zimmerman, Hyman J ^b  

^a GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0345189329     PISSN: 00903159     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Zimmerman HJ: Hepatotoxicity: The Adverse Effects of Drugs and Other Chemicals on the Liver. New York, Appleton-Century-Crofts, 1978
2. Lewis JH: Hepatic toxicity of nonsteroidal anti-inflammatory drugs. Clin Pharm 1984;3:128
3. Zimmerman HJ, Maddrey WC: Toxic and drug-induced hepatitis, in Schiff L, Schiff ER (eds): Diseases of the Liver. 6th ed. Philadelphia, JP Lippincott, 1993, pp 707-769
4. Koff RS: Liver disease induced by nonsteroidal anti-inflammatory drugs, in Borda JT, Koff RS (eds): NSAIDs: A Profile of Adverse Effects. St. Louis, Mosby-Year Book, Inc., 1992, pp 133-145
5. Paulus HE: PDA Arthritis Advisory Committee meeting. Arthritis Rheum 1982;25:1124
6. Katz LM, Love PY: NSAIDs and the liver, in Famaey JE, Paulus HE (eds): Therapeutic Applications of NSAIDs: Subpopulation and New Formulations. New York, Marcel Dekker, 1992, pp 247-263
7. Roth SH, Bennett RE: Nonsteroidal anti-inflammatory drug gastropathy. Recognition and response. Arch Intern Med 1987;147:2093
8. Carson JL, Strom BL, Duff A, et al: Safety of nonsteroidal anti-inflammatory drugs with respect to acute liver disease. Arch Intern Med 1993;153:1331
9. Garcia-Rodriguez LA, Perez-Gutthann S, Walker AM, et al: The role of nonsteroidal anti-inflammatory drugs in acute liver injury. Br Med J 1992;305:865
10. Friis H, Andreasen PB: Drug-induced hepatic injury: An analysis of 1,100 cases reported to the Danish Committee on Adverse Drug Reactions between 1978 and 1987. J Intern Med 1992;232:133
11. Kromann-Andersen H, Pedersen A: Reported adverse reactions to and consumption of nonsteroidal anti-inflammatory drugs in Denmark over a 17-year period. Danish Med Bud 1988;35:187
12. Weinblatt ME, Tesser JR, Gilliam JH, et al: The liver in rheumatic diseases. Semin Arthritis Rheum 1982;11:399
13. Runyon BA, LaBrecque DR, Anuras S: The spectrum of liver disease in systemic lupus erythematosus: Report of 33 histologically proved cases and review of the literature. Am J Med 1980;69:187
14. Zimmerman HJ: Effects of aspirin and acetaminophen on the liver. Arch Intern Med 1981;141(3 Spec No):333
15. Soller RW, Stander H: Association between salicylates and Reye's syndrome. JAMA 1983;249:883
16. Peters W, Wiener GJ, Gilliam J, et al: Reye's syndrome in adults: A case report and review of the literature. Arch Intern Med 1986;146:2401
17. Hurwitz ES, Barrett MJ, Bregman D, et al: Public Health Service study of Reye's syndrome and medications: Report of the main study. JAMA 1967;257:1905
18. White JM: Reye's syndrome and salicylates. JAMA 1987;258:3117 Letter
19. Cook DJ, Achong MR, Murphy FR: Three cases of diflunisal hypersensitivity. Can Med Assoc J 1988;138:1029
20. Symon DN, Gray ES, Hanmer OJ, et al: Fatal paracetamol poisoning from benorylate therapy in child with cystic fibrosis. Lancet 1982;2:1153
21. Helfgott SM, Sanberg-Cook J, Zakim D, et al: Diclofenac-associated hepatotoxicity. JAMA 1990;264:2660
22. Banks AT, Zimmerman HJ, Ishak KG, et al: Diclofenac-associated hepatotoxicity: Analysis of 180 cases reported to the Food and Drug Administration. Hepatology 1995;22:820
23. Scully W, Clarke D, Barr RJ: Diclofenac induced he-patitis: Three cases with features of autoimmune chronic hepatitis. Dig Dis Sci 1993;38:744
24. Purcell P, Henry D, Melville G: Diclofenac hepatitis. Gut 1991;32:1381
25. Cuthbert MG: Adverse reactions to nonsteroidal anti-inflammatory drugs. Curr Med Res Opin 1974;2:12
26. Jacobs JS: Sudden death in arthritic children receiving large doses of indomethacin. JAMA 1967;199:93
27. Terazi EM, Harter JG, Zimmerman HJ, et al: Sulindac-associated hepatic injury: Analysis of 91 cases reported to the Food and Drug Administration. Gastroenterology 1992;104:569
28. Stricker BH: Drug-Induced Hepatic Injury. 2nd ed. Amsterdam, Elsevier, 1992
29. Schattenkirchner M: An updated safety profile of etodolac in several thousand patients. Eur J Rheumatol Inflamm 1990;10:56
30. Mabee CL, Mabee SW, Baker PB, et al: Fulminant hepatic failure associated with etodolac use. Am J Gastroenterol 1995;90:659
31. Halsey J, Cardoe N: Benoxaprofen: Side effects profile in 300 patients. Br Med J (Clin Res Ed) 1962;284:1365
32. Taggart HM, Alderdice JM: Fatal cholestatic jaundice in elderly patients taking benoxaprofen. Br Med J (Clin Res Ed) 1982;284:1372
33. Prescott LE, Leslie PJ, Padfield P: Side effects of benoxaprofen. Br Med J 1982;284:1782
34. Sternleib P, Robinson RM: Stevens-Johnson syndrome plus toxic hepatitis due to ibuprofen. NY State J Med 1978;78 1239
35. Zimmerman HJ: Update of hepatotoxicity due to classes of drugs in common clinical use: Nonsteroidal anti-inflammatory drugs, antibiotics, antihypertensives, and cardiac and psychotropic agents. Semin Liver Dis 1990;10:322
36. Lee CY, Rnkler A: Acute intoxication due to ibuprofen overdose. Arch Pathol Lab Med 1986;110:747
37. Giarelli L, Falconieri G, Delender M: Fulminant hepatitis following naproxen administration. Hum Pathol 1986;17:1079
38. Brogden RN, Heel RC, Speight TM, et al: Fenoprofen: A review of its pharmacological properties and therapeutic use in rheumatic diseases and acute pain. Drugs 1981;21:1
39. Zimmerman HJ: Hepatic effects of oxaprozin. Semin Arthritis Rheum 1986;15:35
40. Purdum PE Shelden SL, Boyd JW, et al: Oxaprozin-induced fulminant hepatitis. Ann Pharmacother 1994;28:1159
41. Carpenter SL, McDonnell WM: Misuse of veterinary phenylbutazone. Arch Intern Med 1995;155:1229
42. Howrie DL, Gartner JC Jr: Gold-induced hepatotoxicity: Case report and review of the literature. J Rheumatol 1982;9:727
43. Fleischner GM, Morecski R, Hanaichi T, et al: Light-and electron-microscopical study of a case of gold salt-induced hepatotoxicity. Hepatology 1991;14:422
44. AI-Kawas FH, Seeff LB, Berendson RA, et al: Allopurinol hepatotoxicity: Report of two cases and review of literature. Ann Intern Med 1981;95:588
45. Vanderstigel M, Zafrani ES, Lejonc JL, et al: Allopurinol hypersensitivity syndrome as a cause of hepatic fibrin-ring granulomas. Gastroenterol 1986;90:188
46. Schiff ER: Can we prevent nonsteroidal anti-inflammatory drug-induced hepatic failure? Gastrointest Dis Today 1994;3:768